New hormonal pathway links oxytocin to insulin secretion in the pancreas
2025-06-17
(Press-News.org)
“Although the detailed mechanism for the stimulation of intra-islet GLP-1 secretion remains to be elucidated and further studies are required, as far as we know, our present study is the first to report the effect of Oxt on inducing intra-islet GLP-1 secretion.”
BUFFALO, NY — June 17, 2025 — A new research paper was published in Aging (Aging-US) Volume 17, Issue 5, on May 1, 2025, titled “Oxytocin modulates insulin and GLP-1 secretion in pancreatic islets.”
In this study, scientists from Fukushima Medical University School of Medicine investigated how the hormone oxytocin (Oxt) influences insulin levels by acting on specific cells in the pancreas. The team led by first author Kasumi Hattori and corresponding authors Kenju Shimomura and Yuko Maejima discovered that oxytocin may indirectly increase insulin secretion by triggering another hormone, GLP-1, from within the pancreas. This finding could lead to new strategies for improving blood sugar control in people with diabetes.
Oxytocin is commonly known for its roles in childbirth and social bonding, but scientists have also been exploring its effects on metabolism. While previous studies offered mixed results about whether oxytocin raises or lowers blood sugar, this research brings new clarity. The study focused on oxytocin’s impact on insulin and a hormone called GLP-1, which helps regulate insulin production. Researchers tested this by using mice with and without oxytocin receptors and found that oxytocin’s ability to raise insulin levels depended on the presence of these receptors and high blood sugar conditions.
Researchers found that oxytocin stimulates the release of “intra-islet GLP-1,” a form of GLP-1 produced inside the pancreas rather than the intestine. In the pancreas, insulin is produced by beta cells, while alpha cells produce glucagon, a hormone that raises blood sugar. But recent research, including this study, has shown that alpha cells can also release GLP-1, which in turn helps beta cells secrete insulin. Oxytocin appears to increase this internal GLP-1 release, especially when blood sugar levels are high, thereby leading to insulin release in a natural and targeted way.
In this study researchers were also able to detect the difference between oxytocin’s effect on blood sugar and its effect on insulin. They observed that right after oxytocin was given, blood sugar levels rose in all mice—even in those that lacked oxytocin receptors. However, only the mice with working oxytocin receptors showed a later increase in insulin. This suggests that oxytocin may trigger insulin production through a separate, receptor-dependent pathway involving the hormone GLP-1.
“WT mice showed a significant increase in insulin levels at 15-min, while OxtR KO mice did not.”
This indirect action—oxytocin triggering alpha cells to release GLP-1, which then acts on beta cells—may represent a novel mechanism for controlling insulin release. It also explains why oxytocin does not increase insulin in low-glucose conditions, making it a potentially safer option for regulating blood sugar.
As treatments for type 2 diabetes increasingly focus on GLP-1–based drugs, this study opens the door to using oxytocin or similar compounds to naturally enhance the body’s own insulin-producing system. With further research, this mechanism could help develop new therapies that better mimic the body’s natural glucose control, particularly beneficial for older adults with diabetes.
Read the full paper: DOI: https://doi.org/10.18632/aging.206244
Corresponding authors: Kenju Shimomura – shimomur@fmu.ac.jp and Yuko Maejima – maejimay@fmu.ac.jp
Keywords: aging, glucagon, insulin, intra-islet GLP-1, oxytocin
Click here to sign up for free Altmetric alerts about this article.
______
To learn more about the journal, please visit our website at www.Aging-US.com and connect with us on social media at:
Facebook
X
Instagram
YouTube
LinkedIn
Reddit
Bluesky
Pinterest
Spotify, and available wherever you listen to podcasts
Click here to subscribe to Aging publication updates.
For media inquiries, please contact media@impactjournals.com.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-06-17
gastroesophageal reflux disease (GERD) is a prevalent gastrointestinal disorder, with up to 20% of patients developing complications like Erosive esophagitis (EE), Barrett’s esophagus, and esophageal adenocarcinoma. EE, characterized by mucosal necrosis and erosions, presents with symptoms ranging from heartburn to dysphagia and gastrointestinal bleeding. Despite effective pharmacologic treatments, 15% of patients exhibit refractory disease. This review synthesizes current evidence to guide clinicians in diagnosing and managing EE, balancing pharmacologic ...
2025-06-17
Key Takeaways
Order matters: The sequence of colorectal cancer (CRC) diagnosis matters for patients with multiple primary cancers. Patients diagnosed with CRC first fared better than those diagnosed with a different cancer first.
Better prognosis than CRC alone: CRC diagnosed as the first of multiple primary malignancies is associated with better overall and cancer-specific survival compared to just CRC or CRC as a second primary cancer.
Hope, with a caveat: Patients who survive CRC have better prospects when ...
2025-06-17
Miami (June 17, 2025) – Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study. The study is published in the May 2025 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, a peer-reviewed, open-access journal.
COPD is an inflammatory lung disease, comprising several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke or pollution. The disease affects more than 30 million Americans and is the fourth leading ...
2025-06-17
Living close to cyanobacterial harmful algal blooms — which are present nationwide but are more common in coastal and Great Lake states — heightens the rate of dying from amyotrophic lateral sclerosis, or ALS, a study suggests.
These blooms occur when cyanobacteria, also called blue-green algae, grows dense and out of control, producing toxic agents that can poison people and the environment.
Researchers at Michigan Medicine surveyed participants with ALS who were seen at the University ...
2025-06-17
Background and objectives
Propolis is a resinous material produced by honeybees. Its chemical composition is highly complex and varies significantly depending on geographic region and season. This intrinsic variability presents challenges to the standardization and quality control of propolis. This study aimed to evaluate the chemical composition, total phenolic content, and antioxidant potential of propolis collected from seventeen geographical regions across Africa.
Methods
A reverse-phase high-performance ...
2025-06-17
New York, NY [June 17, 2025]—In a new collaboration that could transform how cancer is treated, OCCAM Immune—a Mount Sinai initiative focused on understanding the immune system’s role in disease—is partnering with the Cancer Research Institute (CRI) to unlock the secrets of how the immune system responds to advanced therapies.
Under the agreement, OCCAM Immune and CRI have established a long-term plan to support ongoing immune monitoring across CRI’s clinical trials. The collaboration ...
2025-06-17
Suicide remains one of the most pressing public health crises affecting young adults today, with devastating consequences. According to the United States Centers for Disease Control and Prevention, suicide is currently the third leading cause of death among individuals aged 18 to 25, with a 51% increase in suicide deaths between 2000 and 2021.
While this trend is deeply concerning for the general population, it is even more alarming for young adults living with intellectual and developmental disabilities (IDD) – a group long overlooked in suicide prevention efforts.
Research ...
2025-06-17
In recent years, Mendelian randomisation (MR) has revolutionised observational epidemiology by offering a tool to infer causal relationships using genetic variants as instrumental variables (IVs). However, its popularity has come at a cost. The editorial by Chen, Guillot, and Schneider in eGastroenterology (2025) titled "Attention to the misuse of Mendelian randomisation in medical research" delivers a timely critique of the field's current trajectory. As MR studies surge, so too do concerns about their quality and interpretive validity. The authors call for stricter methodological scrutiny and offer practical recommendations ...
2025-06-17
AI can help public health agencies in the quest to end HIV. The United States is pursuing an initiative to end the HIV epidemic by 2030. To achieve this goal, public health agencies and organizations must remind the public about how best to avoid transmitting and acquiring the virus. Public health campaigns are costly, their effectiveness is seldom systematically assessed, and no systematic methods have been developed to build health campaigns in real-time. Dolores Albarracin and colleagues collected public health messages about HIV prevention and testing from US federal agencies, non-profit organizations, ...
2025-06-17
Gene editing could be used to treat millions of glaucoma patients. Glaucoma is a leading cause of blindness, characterized by high pressure inside the eye. Patients often rely on daily eye drops to lower intraocular pressure, but the drops may cause significant complications including bradycardia, metabolic acidosis, and kidney stones. In addition, many patients fail to keep up with the eye drops. Yang Sun and colleagues used the CRISPR gene editing technique to knock down two genes associated with the production ...
LAST 30 PRESS RELEASES:
[Press-News.org] New hormonal pathway links oxytocin to insulin secretion in the pancreas
